Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
ADP plays a critical role in modulating thrombosis and hemostasis. ADP initiates platelet aggregation by simultaneous activation of two G protein-coupled receptors, P2Y1 and P2Y12. Activation of P2Y1 activates phospholipase C and triggers shape change, while P2Y12 couples to Gi to reduce adenylyl cyclase activity. P2Y12 has been shown to be the target of the thienopyridine drugs, ticlopidine and clopidogrel. Recently, we cloned a human orphan receptor, SP1999, highly expressed in brain and platelets, which responded to ADP and had a pharmacological profile similar to that of P2Y12. To determine whether SP1999 is P2Y12, we generated SP1999-null mice. These mice appear normal, but they exhibit highly prolonged bleeding times, and their platelets aggregate poorly in responses to ADP and display a reduced sensitivity to thrombin and collagen. These platelets retain normal shape change and calcium flux in response to ADP but fail to inhibit adenylyl cyclase. In addition, oral clopidogrel does not inhibit aggregation responses to ADP in these mice. These results demonstrate that SP1999 is indeed the elusive receptor, P2Y12. Identification of the target receptor of the thienopyridine drugs affords us a better understanding of platelet function and provides tools that may lead to the discovery of more effective antithrombotic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H., & Coughlin, S. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6042 · Cited by 841
Jin, J., & Kunapuli, S. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8070 · Cited by 540
Quinn, M. J., & Fitzgerald, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.15.1667 · Cited by 496
Molecular Basis for ADP-induced Platelet Activation
Jin, J., Daniel, J. L., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2030 · Cited by 477
Léon, C., Hechler, B., Freund, M., Eckly, A., Vial, C., Ohlmann, P., Dierich, A., LeMeur, M., Cazenave, J.-P., & Gachet, C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8399 · Cited by 460
Molecular Basis for ADP-induced Platelet Activation
Daniel, J. L., Dangelmaier, C., Jin, J., Ashby, B., Smith, J. B., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2024 · Cited by 441
Fabre, J.-E., Nguyen, M., Latour, A., Keifer, J. A., Audoly, L. P., Coffman, T. M., & Koller, B. H. (1999) · Nature Medicine · doi:10.1038/13522 · Cited by 439
Léon, C., Hechler, B., Vial, C., Leray, C., Cazenave, J.-P., & Gachet, C. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00022-7 · Cited by 296
ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999
Zhang, F. L., Luo, L., Gustafson, E., Lachowicz, J., Smith, M., Qiao, X., Liu, Y.-H., Chen, G., Pramanik, B., Laz, T. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009718200 · Cited by 221
Self-citation
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542
Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Purine and pyrimidine receptors
Burnstock, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6497-0 · Cited by 929
Signaling During Platelet Adhesion and Activation
Li, Z., Delaney, M. K., O'Brien, K. A., & Du, X. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207522 · Cited by 911
Activation of Platelet Function Through G Protein–Coupled Receptors
Offermanns, S. (2006) · Circulation Research · doi:10.1161/01.res.0000251742.71301.16 · Cited by 725
“Platelet activation by ADP is mediated by 2 G protein-coupled receptors, P2Y1 and P2Y12.”
BackgroundPurinergic Signaling during Inflammation
Eltzschig, H. K., Sitkovsky, M. V., & Robson, S. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1205750 · Cited by 706
Platelet-neutrophil-interactions: Linking hemostasis and inflammation
Zarbock, A., Polanowska-Grabowska, R. K., & Ley, K. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.06.001 · Cited by 651
Purinergic Signaling during Inflammation
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1300259 · Cited by 608
Central role of the P2Y12 receptor in platelet activation
Dorsam, R. T., & Kunapuli, S. P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420986 · Cited by 594
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
von Kügelgen, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.014 · Cited by 541
Platelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
Fontana, P., Dupont, A., Gandrille, S., Bachelot-Loza, C., Reny, J.-L., Aiach, M., & Gaussem, P. (2003) · Circulation · doi:10.1161/01.cir.0000085073.69189.88 · Cited by 425
Thrombin and Platelet Activation
Brass, L. F. (2003) · Chest · doi:10.1378/chest.124.3_suppl.18s · Cited by 404
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Purinergic receptor P2RY12-dependent microglial closure of the injured blood–brain barrier
Lou, N., Takano, T., Pei, Y., Xavier, A. L., Goldman, S. A., & Nedergaard, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520398113 · Cited by 364
André, P., Delaney, S. M., LaRocca, T., Vincent, D., DeGuzman, F., Jurek, M., Koller, B., Phillips, D. R., & Conley, P. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17864 · Cited by 359
Purine and Pyrimidine (P2) Receptors as Drug Targets
Jacobson, K. A., Jarvis, M. F., & Williams, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020046y · Cited by 352
P2 receptors in cardiovascular regulation and disease
Erlinge, D., & Burnstock, G. (2008) · Purinergic Signalling · doi:10.1007/s11302-007-9078-7 · Cited by 344
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
P2 receptors, platelet function and pharmacological implications
Gachet, C. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-11-0673 · Cited by 297
Altered immune response in mice deficient for the G protein-coupled receptor GPR34
Liebscher, I., Müller, U., Teupser, D., Engemaier, E., Engel, K. M. Y., Ritscher, L., Thor, D., Sangkuhl, K., Ricken, A., Wurm, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.196659 · Cited by 106
Metadata
- Authors
- Foster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma, F. J., Wiekowski, M. T., Abbondanzo, S. J., Cook, D. N., Bayne, M. L., Lira, S. A., & Chintala, M. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-06-15
- Volume
- 107
- Issue
- 12
- Pages
- 1591-1598
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2170062988
- Cited by
- 415
- References
- 21
- FWCI
- 22.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.